Compassionate use of remdesir and convalescent plasma therapy for the treatment of COVID-19 infection in Nepal: a prospective observational study
Executive Summary: Background As of December 2020, the COVID-19 pandemic has infected over 80 million people and caused over 1.7 million deaths worldwide. Over 250 thousand cases of infection and over 1800 deaths have occurred in Nepal. An approved antiviral therapy for the treatment of COVID-19 i...
محفوظ في:
المؤلفون الرئيسيون: | Gyanwali, Pradeep, Bhattarai, Saroj, Dhimal, Meghnath |
---|---|
التنسيق: | Technical Report |
اللغة: | en_US |
منشور في: |
Nepal Health Research Council
2021
|
الموضوعات: | |
الوصول للمادة أونلاين: | http://103.69.126.140:8080/handle/123456789/743 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Assessment of health status of home isolated COVID-19 patients in Nepal
بواسطة: Gyanwali, Pradeep, وآخرون
منشور في: (2021) -
Assessment of status of post-recovery patients with COVID-19 infections in Nepal
بواسطة: Gyanwali, Pradeep, وآخرون
منشور في: (2021) -
Compassionate use of remdesir and convalescent plasma therapy for the treatment of COVID-19 infection in Nepal: a prospective observational study.
منشور في: (2021) -
Responding to COVID-19: health sector preparedness, response and lessons learnt
منشور في: (2021) -
Covid-19: Effect of lockdown on mental and physical health.
بواسطة: Gautam, Dikshya
منشور في: (2020)